Charles Rosier: Flavors.me
Charles Rosier (flavors.me/) took two years of additional classes in preparation for accomplishing further French certifications. Charles Rosier earned his first scientific Baccalaureate degree (which is same as A-levels in the UK). Whilst pursuing his job, he occupied several different positions, which transformed him into experienced banker.
Charles Rosier's Environmental Projects
Charles Rosier funded MPOWERD to develop other energy solutions like lanterns. With this, MPOWERD delivered these efficient solutions to more than 25 poor nations around the planet. He has contributed a lot to solving various environmental problems and has helped to develop energy and power sectors, particularly in poor countries. Charles Rosier is a partner at Innoveox, a French organisation working on fostering a friendly and pollution-free atmosphere. Economical LED lanterns were specifically developed by MPOWERD to provide cost-effective energy solutions to poor countries.
Charles Rosier: Successful Healthcare Projects
Charles Rosier was the project’s major investor. A drug treatment for strokes that can cause spinal cord injury was being tested. Because of the investment provided by him, the organisation was able to conduct research and give a percentage of their profit to him. He financed Mapreg, a laboratory based in Paris, in order to do research regarding stroke, depression and other serious diseases. Charles Rosier started a healthcare project as an investor at Mapreg, a pharmaceutical firm headed by Professor Etienne Baulieu.
Charles Rosier and His Chosen Career
In August 2010, Charles Rosier became a member of BTG Pactual. In addition to this, he became a partner there. BTG Pactual is an investment bank in Latin America. His appointment at Lehman Brothers in 1996 was his first step towards his future. Then he went to UBS Warburg and became the manager of their Debt Capital Market Division in 1997. Charles Rosier was held responsible for the French-speaking markets of France, Belgium and Quebec at UBS Warburg.